Treatment Ridgeview Research Studied Now FDA Approved!
Ridgeview Research, with principle investigators Ravi Vaela, MD, Ridgeview Medical Center, and James Lehmann, MD, now retired from Ridgeview Medical Center, participated in a nationwide gout study from March 2003 to March 2008 with pharmaceutical company Takeda. The study involved the use of the medication Uloric®, which has now been approved by the FDA to fight gout. This once-daily, oral medication is the first new treatment option for gout in more than 40 years.
Thanks to 34 local research participants, Ridgeview Research is making a difference in health care and improving the lives of those individuals with gout. For more information on this medication and the study, please visit www.ULORIC.com or Medical News Today.
Ridgeview Research is currently recruiting for the following studies: migraine, gout, prostate cancer, chronic constipation, gerd (acid reflux), pink eye, actinic keratosis and postmenopause.
Specialized nurses, physicians and staff work with study participants to coordinate care and follow up. Participants may also be compensated for their time and travel.
If you or someone you know is interested in participating in a study, please visit the Ridgeview Research Web page or call the clinic, located in the Ridgeview Chaska Medical Plaza, at (952) 556-2687.